1SingerCF,KubistaE,GarmroudiF,etal.Localfeedbackmechanismsinhumanbreastcancer[].Breast Cancer Research and Treatment.2000
2SieuwertsAM,KlijnJG,Henzen-LogmandSC,etal.Urokinase-type-plasminogen-activator(uPA)productionbyhumanbreast(myo)fibroblastsinvitro:influenceoftransforminggrowthfactor-beta(1)(TGFbeta(1))comparedwithfactor(s)releasedbyhumanepithelial-carcinomacells犤J犦[].International Journal of Cancer.1998
3Gebauer G,Fehn T,Merkle E,et al.Epithelial cells in bone marrow of breast cancer patients at time of primary surgrey:clinical outcome during long-term follow-up[J].J.Clin Oncol,2001,19(21):3669-3674.
4Li J,Yen C,Liaw D,et al.PTEN,a putative protein tyrosine phosphatase gene mutated in human brain,breast,and prostate cancer[J].Science,1997,275(5308):1943-1947.
5Li D M,Sun H.TEP1,encoded by a candidate tumor suppressor locus,is a novel protein tyrosine phosphatase regulated by transforming growth factor beta[J].Cancer Res,1997,57(11):2124-2129.
6Millis R R,Springall R,Lee A H,et al.Occult axillary lymph node metastases are of no prognostic significance in breast cancer[J].Br J Cancer,2002,86(3):396-401.
7de-Mascarel I,MacGrogan G,Picot V,et al.Prognostic significance of immunohistochemically detected breast cancer node metastases in 218 patients[J].Br J Cancer,2000,87(1):70-74.
8Umekita Y,Ohi Y,Sagara Y,et al.Clinical significance of occult micrometastases in axillary lymph nodes in "node-negative" breast cancer patients[J].Jpn J Cancer Res,2002,93(6):695-698.
9Depowski P L,Rosenthal S I,Ross J S.Loss of expression of the PTEN gene protein product is associated with poor outcome in breast cancer[J].Mod Pathol,2001,14(7):672-676.
10Kim YW,Kim SK,Youn HJ,et al.The clinical utility of automated breast volume scanner:a pilot study of 139 cases[J].J Breast Cancer,2013,16:329-334.
